Table 1.
Treatment | Stimulation rate (Hz) | Sex | % Change in APD90 | n | Number of animals |
---|---|---|---|---|---|
Krebs buffera | 3.33 | Male | −38.2±1.7 | 17 | 16 |
Female | −36.9±2.0NS | 19 | 17 | ||
0.2 | Male | 11.0±1.2 | 31b | 24 | |
Female | 16.2±1.3* | 32b | 28 | ||
BaCl2 (10 μM)c | 3.33 | Male | 8.0±1.2 | 5 | 4 |
Female | 7.0±0.9NS | 6 | 4 | ||
1.0 | Male | 12.2±3.0 | 5 | 5 | |
Female | 11.4±1.9NS | 6 | 5 | ||
0.2 | Male | 18.6±4.0 | 5 | 5 | |
Female | 14.7±3.9NS | 6 | 5 | ||
(−) chromanol 293B (10 μM)c | 3.33 | Male | −0.6±1.2 | 4 | 4 |
Female | −0.2±0.6NS | 4 | 4 | ||
1.0 | Male | −0.2±0.7 | 4 | 4 | |
Female | 1.4±1.3NS | 4 | 4 | ||
0.2 | Male | 0.2±1.3 | 4 | 4 | |
Female | 1.8±2.2NS | 4 | 4 |
APD90: the duration of action potential at 90% repolarisation. Data are expressed as mean±s.e.m.
Data are expressed as a per cent change relative to APD90 at 1.0 Hz in Krebs buffer.
Data were obtained in this study and Abi-Gerges et al. (2004a).
Data are expressed as a per cent change relative to APD90 at the same stimulation rate in Krebs buffer.
P>0.05
P<0.01 versus values from male animals.